Not yet recruiting
Iparomlimab and Tuvonralimab Combined With Chemotherapy and Bevacizumab as Neoadjuvant Therapy for Locally Advanced Rectal Cancer
NCT07769853
- Conditions
- 5-12cm to Anal Verge, Locally Advanced Rectal Cancer (LARC)
- Locations
-
Not specified